三元生物
(301206)
| 流通市值：30.81亿 | | | 总市值：47.85亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 428,710,939.19 | 224,781,048.39 | 649,511,864.38 | 476,077,165.85 |
| 营业收入 | 428,710,939.19 | 224,781,048.39 | 649,511,864.38 | 476,077,165.85 |
| 二、营业总成本 | 395,448,253.26 | 208,040,014.29 | 615,716,180.92 | 450,764,643.46 |
| 营业成本 | 353,285,056.17 | 187,322,978.08 | 544,823,711.67 | 399,176,492.76 |
| 税金及附加 | 2,298,645.06 | 1,113,492.98 | 3,673,146.79 | 2,799,751.11 |
| 销售费用 | 5,011,085.88 | 2,810,922.54 | 8,355,078.22 | 6,176,169.39 |
| 管理费用 | 13,847,679.31 | 7,359,170.98 | 29,519,901.83 | 23,135,356.52 |
| 研发费用 | 18,690,189.28 | 8,240,074.81 | 34,417,125.92 | 24,800,042.4 |
| 财务费用 | 2,315,597.56 | 1,193,374.9 | -5,072,783.51 | -5,323,168.72 |
| 其中:利息收入 | 3,000,177.68 | 1,946,448.93 | 6,713,474.49 | 5,514,743.71 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,717,740.7 | 1,945,644.14 | 367,116.65 | - |
| 加:投资收益 | 23,143,436.07 | 9,953,485.08 | 69,511,758.02 | 51,329,576.12 |
| 资产处置收益 | - | - | 65,753.16 | 10,577.18 |
| 资产减值损失(新) | -2,133,048.7 | -138,865.95 | -272,312.9 | - |
| 信用减值损失(新) | 290,137.99 | 202,024.25 | 168,848.15 | 72,740.76 |
| 其他收益 | 1,199,535.15 | 726,757.42 | 1,402,320.54 | 1,057,160.99 |
| 四、营业利润 | 57,480,487.14 | 29,430,079.04 | 105,039,167.08 | 77,782,577.44 |
| 加:营业外收入 | 31,708.59 | 18,891.6 | 482,257.96 | 80,912.69 |
| 减:营业外支出 | 10,925.1 | 56.04 | 94,336.04 | 94,333.49 |
| 五、利润总额 | 57,501,270.63 | 29,448,914.6 | 105,427,089 | 77,769,156.64 |
| 减:所得税费用 | 7,103,683.83 | 3,357,470.3 | 14,130,529.04 | 10,484,491.79 |
| 六、净利润 | 50,397,586.8 | 26,091,444.3 | 91,296,559.96 | 67,284,664.85 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 50,397,586.8 | 26,091,444.3 | 91,296,559.96 | 67,284,664.85 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 50,397,586.8 | 26,091,444.3 | 91,410,640.59 | 67,398,745.48 |
| 少数股东损益 | - | - | -114,080.63 | -114,080.63 |
| 扣除非经常损益后的净利润 | 42,941,503.4 | 22,862,806.87 | 75,935,866.28 | 57,134,312.53 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.25 | 0.13 | 0.46 | 0.34 |
| (二)稀释每股收益 | 0.25 | 0.13 | 0.46 | 0.34 |
| 八、其他综合收益 | -124,469.69 | -160,103.28 | 158,013.72 | - |
| 归属于母公司股东的其他综合收益 | -124,469.69 | -160,103.28 | 158,013.72 | - |
| 九、综合收益总额 | 50,273,117.11 | 25,931,341.02 | 91,454,573.68 | 67,284,664.85 |
| 归属于母公司股东的综合收益总额 | 50,273,117.11 | 25,931,341.02 | 91,568,654.31 | 67,398,745.48 |
| 归属于少数股东的综合收益总额 | - | - | -114,080.63 | -114,080.63 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |